SCHEMBL10441259

SCHEMBL10441259

CCc1c(C(C)C)cnc2nc[nH]c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.38
▸ HTT P42858 4/20 0.37
▸ MAP3K5 Q99683 1/20 0.37
▸ CDK2 P24941 5/20 0.36
▸ CDK1 P06493 4/20 0.36
▸ CCNB1 P14635 4/20 0.36
▸ CCNA2 P20248 4/20 0.36
▸ CCNA1 P78396 4/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ TP53 P04637 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ PAK1 Q13153 1/20 0.36
▸ NCOA1 Q15788 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ PDPK1 O15530 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ LRRK2 Q5S007 2/20 0.35
▸ CHEK1 O14757 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9203151 0.77 ALDH1A1 (0.47) ALDH1A1HTTCDK2CDK1CCNB1
SCHEMBL21334364 0.71 ALDH1A1 (0.41) ALDH1A1HTTMAP3K5CDK2CDK1
SCHEMBL10441257 0.69 BRD4 (0.42) ALDH1A1CDK2CDK1CCNB1CCNA2
SCHEMBL23771325 0.68 ALDH1A1 (0.50) ALDH1A1HTTMAP3K5CDK2NPC1
SCHEMBL24995901 0.68 CDK2 (0.43) MAP3K5CDK2CDK1CCNB1CCNA2
SCHEMBL19851801 0.66 NOS3 (0.31) ALDH1A1KDM4EHSD17B10
SCHEMBL8691506 0.64 BRD4 (0.38) ALDH1A1HTTMAP3K5CDK2CDK1
SCHEMBL12338166 0.64 CYP1A2 (0.39) ALDH1A1KDM4EHSD17B10LMNA
SCHEMBL10274929 0.63 LRRK2 (0.52) ALDH1A1HTTMAP3K5CDK2TP53
SCHEMBL2930055 0.63 HSD17B10 (0.56) HTTMAP3K5CDK2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0400974-A2 Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists MERCK & CO. INC. (US) 1990-12-05 — — EP disclosed
Send feedback